Team:Aberdeen Scotland

From 2014.igem.org

(Difference between revisions)
Line 58: Line 58:
<div class="t_overview">
<div class="t_overview">
<h1>Aberdeen iGEM Team 2014</h1>
<h1>Aberdeen iGEM Team 2014</h1>
-
<h3>Wake up to the Sleeping Sickness</h3>
+
<h3>Human African Trypanosomiasis – a Neglected Tropical Disease/h3>
</div> <br class="clear"> <!-- END OF HEAD -->
</div> <br class="clear"> <!-- END OF HEAD -->
<!-- PAGE CONTENT -->
<!-- PAGE CONTENT -->
<div class="main_content">
<div class="main_content">
-
<p>Hi, there. We are a team of Aberdeen Uni undergrads trying to do our part in the fight against Sleeping Sickness. There's six of us - 5 biologists and 1 physicist. We are very excited to be able to take part in iGEM and we would like to take you on a tour around our project.</p>
+
<p>Trypanosoma brucei gambiense, the causative agent of Human African Trypanosomiasis (HAT) (commonly known as African Sleeping Sickness), infects 30,000 people worldwide, with 60 million at disease risk. Unrecognised, this disease is fatal, but accurate diagnosis, relying on detection of patient serum antibodies against two different trypanosomal antigens, Variable Surface Glycoprotein LiTat 1.3 and Variable Surface Glycoprotein LiTat 1.5, allows successful treatment</p>
-
<p>We have worked all summer towards what we hope would turn out to be some peace of mind for a lot of people. The goal is to develop a novel method for diagnosing Trypanosomiasis. A simpler, cheaper alternative to current methods that would be more versatile in developing countries and their remote regions. We wish to create a test that would be portable, endure harsh environmental conditions and most importantly be sensitive to the early stages of the disease.</p>
+
 
-
<p>This would give a lot of unsuspecting sufferers the chance to get diagnosed early. This way they can get cured quickly, before the disease reaches its later stages, when it is virtually incurable.</p>
+
<h3>Our project and achievements/h3>
 +
</div> <br class="clear"> <!-- END OF HEAD -->
 +
 
 +
<p>We engineered autotransporters Antigen43 (Ag43) and  Ice-Nucleation protein (INP) to successfully express surface epitopes in E.coli, that mimic the two different trypanosomal antigens. Therefore, we created standardised and user-friendly Ag43 and INP BioBricks ready for peptides of choice to be cloned in. Two E.coli strains were generated, each expressing a distinct surface epitope and either a quorum sensing sender or receiver module respectively. We delivered a proof-of-principle demonstration of our project, by showing that the quorum-based system is capable of detecting cell surface Ag43-FLAG ‘Receiver’ E.coli in an anti-FLAG bead pull-down. These ‘Receivers’ co-cultured with AHL-synthesising ‘Senders’ produced a strong –FLAG-tag dependent, AHL-inducible GFP response. This system if applied in a real-life scenario could effectively diagnose a neglected tropical disease such as Trypanosomiasis, using patient serum-derived antibodies, with minimal facilities.</p>
 +
 
 +
<h3>The user-friendly, portable, inexpensive GFP detection device/h3>
 +
</div> <br class="clear"> <!-- END OF HEAD -->
 +
 
 +
<p>We constructed a cheap, Raspberry Pi computer-controlled fluorimeter suitable for developing countries, showing it could detect QS fluorescence output.  The detection device costs around $100 and could replace heavy and expensive microscopes, to make the detection system affordable to remote populations in Africa.</p>
 +
 
 +
<h3>The user-friendly, portable, inexpensive GFP detection device/h3>
 +
</div> <br class="clear"> <!-- END OF HEAD -->
 +
 
 +
<p>This novel application to diagnose patient exposure to tropical pathogens integrates antigen display and quorum sensing to implement AND logic sensing. It facilitates cheap, simple diagnosis of neglected tropical diseases such as HAT. Future diagnosis kits can be constructed and modularized using the cheap and self-replenishing E. coli based detection system we created as a platform for displaying two different mimotopes. Mimotopes are shortened versions of real epitopes identified for a panel of diseases, all of which are currently stored in a universal database, available to everyone and known as MimoDB (INSERT URL here). Moreover, it was recently shown that upon heat-treatment of Ag43 autotransporter-foreign peptide complex at 60°C, a chimeric form of the expressed foreign protein can be isolated and remain fully active. The chimeric protein was then used to induce an immune response and to develop a novel vaccine for cancer therapy ((Huang et al., 2014)). Therefore, we suggest that further research can be done on Ag43-trypanosomal mimotope/ other mimotope complexes for a potential first vaccine for HAT/ other diseases. </p>
 +
 
 +
<p> Reference:  Huang, F., Li, L., Liu, Q., Li, Y., Bai, R., Huang, Y., Zhao, H., Guo, J., Zhou, S., Wang, H. and others, (2014). Bacterial surface display of endoglin by antigen 43 induces antitumor effectiveness via bypassing immunotolerance and inhibition of angiogenesis. International Journal of Cancer, 134(8), pp.1981--1990.</p>
 +
 
 +
 
 +
 
</div>
</div>

Revision as of 06:31, 15 October 2014

Team:Aberdeen Scotland - 2014.ogem.org



Aberdeen iGEM Team 2014

Human African Trypanosomiasis – a Neglected Tropical Disease/h3>


Trypanosoma brucei gambiense, the causative agent of Human African Trypanosomiasis (HAT) (commonly known as African Sleeping Sickness), infects 30,000 people worldwide, with 60 million at disease risk. Unrecognised, this disease is fatal, but accurate diagnosis, relying on detection of patient serum antibodies against two different trypanosomal antigens, Variable Surface Glycoprotein LiTat 1.3 and Variable Surface Glycoprotein LiTat 1.5, allows successful treatment

Our project and achievements/h3>


We engineered autotransporters Antigen43 (Ag43) and Ice-Nucleation protein (INP) to successfully express surface epitopes in E.coli, that mimic the two different trypanosomal antigens. Therefore, we created standardised and user-friendly Ag43 and INP BioBricks ready for peptides of choice to be cloned in. Two E.coli strains were generated, each expressing a distinct surface epitope and either a quorum sensing sender or receiver module respectively. We delivered a proof-of-principle demonstration of our project, by showing that the quorum-based system is capable of detecting cell surface Ag43-FLAG ‘Receiver’ E.coli in an anti-FLAG bead pull-down. These ‘Receivers’ co-cultured with AHL-synthesising ‘Senders’ produced a strong –FLAG-tag dependent, AHL-inducible GFP response. This system if applied in a real-life scenario could effectively diagnose a neglected tropical disease such as Trypanosomiasis, using patient serum-derived antibodies, with minimal facilities.

The user-friendly, portable, inexpensive GFP detection device/h3>


We constructed a cheap, Raspberry Pi computer-controlled fluorimeter suitable for developing countries, showing it could detect QS fluorescence output. The detection device costs around $100 and could replace heavy and expensive microscopes, to make the detection system affordable to remote populations in Africa.

The user-friendly, portable, inexpensive GFP detection device/h3>


This novel application to diagnose patient exposure to tropical pathogens integrates antigen display and quorum sensing to implement AND logic sensing. It facilitates cheap, simple diagnosis of neglected tropical diseases such as HAT. Future diagnosis kits can be constructed and modularized using the cheap and self-replenishing E. coli based detection system we created as a platform for displaying two different mimotopes. Mimotopes are shortened versions of real epitopes identified for a panel of diseases, all of which are currently stored in a universal database, available to everyone and known as MimoDB (INSERT URL here). Moreover, it was recently shown that upon heat-treatment of Ag43 autotransporter-foreign peptide complex at 60°C, a chimeric form of the expressed foreign protein can be isolated and remain fully active. The chimeric protein was then used to induce an immune response and to develop a novel vaccine for cancer therapy ((Huang et al., 2014)). Therefore, we suggest that further research can be done on Ag43-trypanosomal mimotope/ other mimotope complexes for a potential first vaccine for HAT/ other diseases.

Reference: Huang, F., Li, L., Liu, Q., Li, Y., Bai, R., Huang, Y., Zhao, H., Guo, J., Zhou, S., Wang, H. and others, (2014). Bacterial surface display of endoglin by antigen 43 induces antitumor effectiveness via bypassing immunotolerance and inhibition of angiogenesis. International Journal of Cancer, 134(8), pp.1981--1990.

You can find our official iGEM Registry Page here.



Retrieved from "http://2014.igem.org/Team:Aberdeen_Scotland"